U.S. Monkey Vaccine vaccination Avoid racial differences

The latest data from US health institutions show that the number of cases in the United States has the largest number of cases in the world, but the full vaccination rate of monkey acne vaccines is very low, and the racial differences of the vaccination rate are significantly significantly.

According to data released by the US Centers for Disease Control and Prevention on the 26th, as of the 23rd, the United States had vaccinated more than 207,000 doses of acne vaccine, but nearly 97%were the first inoculation.

These vaccines are produced by Bavarian Nordic companies in Denmark and have two inoculation volumes throughout the process, which are around.

The data also shows that about half of the vaccinators are white and about 10%are African descent, while the latter accounts for one -third of the total number of cases. Iwan Labard, head of global health education affairs in Oaksner Health Institutions in the United States, told the Associated Press that this is similar to the racial differences in the new crown vaccine vaccination. "This problem is still not resolved." Some experts believe that the health department needs to take measures to help African people get more vaccination, testing, treatment opportunities and more relevant information.

The number of cumulative cumulative cases in the United States has the largest number of cases in the world. According to data from the US Centers for Disease Control and Prevention, as of the 25th, a total of more than 46,700 cases reported in the world, of which about 17,000 were in the United States. In the week from 18 to 25, the number of American acne cases increased by about 25%.

The U.S. government said on the 26th that the mounted monkey acne vaccine is enough to allow the first dose of the people with the largest risk of infection. It is expected that the number of vaccines required for the second dose can be met at the end of this month.

In early August, the US Food and Drug Administration approved the use of internal internal injection to replace subcutaneous injection. The dosage required in the previous way is only one -fifth of the latter way, so that more people can get vaccination.

However, the Bavarian Nordic Corporation questioned the security of this method, arguing that it lacks data support, and there is evidence that the in -skin injection method may lead to increased side effects.

(Source: Zhonggong.com)

【Edit: Wang Rongfei】

For more exciting content, please download the "Da Wuhan" client in the major application markets.

- END -